文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

预防性甲泼尼龙降低急诊插管后拔管后喘鸣风险:随机对照试验研究方案

Efficacy of prophylactic methylprednisolone on reducing the risk of post-extubation stridor in patients after an emergency intubation: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2021-01-06

本研究为多中心、随机、安慰剂对照试验,计划纳入132例急诊插管后拔管前袖带漏气试验(CLT)失败的患者,比较拔管前4小时静脉给予甲泼尼龙40 mg与安慰剂的疗效,主要终点为拔管后48小时内拔管后喘鸣(PES)发生率。CLT通过者纳入非干预观察组。

要点

  • 急诊插管患者拔管前CLT失败者,随机接受甲泼尼龙40 mg或安慰剂。
  • 主要终点为拔管后48小时内PES发生率。
  • CLT通过者进入非干预观察组,不参与随机比较。

核心结论

  • 评估拔管前单剂甲泼尼龙能否预防急诊插管患者的PES,研究方案已注册待实施。

研究设计与样本

  • 多中心、随机、安慰剂对照试验,急诊科开展,纳入132例拔管前CLT失败患者。
  • 随机分入拔管前4小时静脉甲泼尼龙40 mg组或安慰剂组,CLT通过者纳入非干预观察组。

关键数值与推荐

  • 干预为拔管前4小时静脉甲泼尼龙40 mg,对照为安慰剂。
  • 主要终点为拔管后48小时内PES发生率;次要终点含氧疗、呼吸支持需求、因PES再插管、48小时内不良反应、住院时长及住院死亡率。

局限性

  • 为研究方案,尚未报告疗效与安全性结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Post-extubation stridor (PES) is one of the most common complications of invasive respiratory support, with severe cases leading to possible extubation failure (reintubation within 48 h) and increased mortality. Previous studies confirmed that prophylactic corticosteroids play an important role in reducing the risk of PES and extubation failure. However, few studies have looked at the efficacy of corticosteroids on preventing PES in patients after an emergency intubation. AIM: To evaluate whether a single dose of methylprednisolone given over a set timeframe before extubation is effective in preventing PES in patients after an emergency intubation. METHODS: A multicenter, randomized, placebo-controlled trial will be performed in an emergency department (ED) setting. The trial will include 132 patients who fail a cuff-leak test (CLT) prior to the intervention. Patients will be randomly assigned to either intravenous methylprednisolone (40 mg) or placebo 4 h prior to extubation. Other eligible patients who pass the CLT will be included in a non-intervention (observation) group. The primary endpoint is the incidence of PES within 48 h after extubation. Secondary endpoints include oxygen therapy, respiratory support requirements, reintubation secondary to PES, adverse effects within 48 h after extubation, hospital length of stay, and hospital mortality. DISCUSSION: Patients who are intubated on an emergency basis have a higher risk of intubation-related complications. Previous studies have examined treatment regimens involving more than 10 different variations on corticosteroid treatments for PES prevention, while for ED therapy, only a simple and effective treatment would be appropriate. Corticosteroid administration is usually accompanied by adverse effects; thus, this study will be important for further risk stratification among intubated ED patients. TRIAL REGISTRATION: Chictr.org.cn ChiCTR2000030349 . Registered on 29 February 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang J, Walline JH, Yin L, et al. Efficacy of prophylactic methylprednisolone on reducing the risk of post-extubation stridor in patients after an emergency intubation: study protocol for a randomized controlled trial. Trials. 2021. PMID: 33407774. doi:10.1186/s13063-020-04994-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。